Jubilant Life Sciences Limited announced unaudited consolidated earnings results for the second quarter and six months ended September 30, 2018. For the quarter, the company reported total revenue from operations of INR 22,694.9 million compared to INR 16,420.4 million reported in the same period last year. Total comprehensive income after tax was INR 3,507.1 million compared to INR 2,056.3 million a year ago. Basic and diluted earnings per share were INR 13.50 compared to INR 8.23 a year ago. For the six months, the company reported total revenue from operations of INR 43,481.4 million compared to INR 32,380.9 million reported in the same period last year. Total comprehensive income after tax was INR 5,647.3 million compared to INR 3,888.1 million a year ago. Basic and diluted earnings per share were INR 26.50 compared to INR 17.67 a year ago.